Abstract
No abstract available.
Highlights
As a medical practitioner in the public sector who treats people with depressive disorders almost on a daily basis it came to a shock to me that in the private sector it was not the choice of medication that was not covered but the diagnosis of depressive disorders (F32 and F33) per se was not regarded as a medical condition requiring pharmacological treatment
I used Citalopram and various evidence based nonpharmacological treatments
The WHO World Health Survey studied In South Africa, the lifetime and 12-month prevalence rates for major depressive disorder are 9.7% and 4.9% respectively, with less than a quarter of South Africans with major depressive disorder able to access services and receive treatment.[6]
Summary
As a medical practitioner in the public sector who treats people with depressive disorders almost on a daily basis it came to a shock to me that in the private sector it was not the choice of medication that was not covered but the diagnosis of depressive disorders (F32 and F33) per se was not regarded as a medical condition requiring pharmacological treatment.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
